TY - JOUR
T1 - The Virtual Human Platform for Safety Assessment (VHP4Safety) project
T2 - Next generation chemical safety assessment based on human data
AU - Kienhuis, Anne
AU - Krul, Cyrille
AU - van Engelen, Jacqueline
AU - Evelo, Chris T
AU - Hessel, Ellen
AU - Hoekman, Jarno
AU - Kramer, Nynke
AU - Krop, Esmeralda
AU - Masereeuw, Rosalinde
AU - Moors, Ellen
AU - Negro, Simona O
AU - Piersma, Aldert H
AU - Pieters, Raymond
AU - Teunis, Marc
AU - Willighagen, Egon
AU - Legler, Juliette
PY - 2025
Y1 - 2025
N2 - The Virtual Human Platform for Safety Assessment (VHP4Safety) project aims to build a virtual human platform (VHP) to protect human health and revolutionize the safety assessment of chemicals and pharmaceuticals by transitioning from animal-based to human-based approaches. The goal of this article is to introduce the project and its interdisciplinary approach to co-creation with multiple academic, regulatory, industrial and societal partners covering the entire safety assessment knowledge chain. Three research lines drive the project: 1) building the VHP; 2) feeding the VHP with human data; and 3) implementing the VHP. The project focusses on three case studies that incorporate human-relevant scenarios not included in current animal-based safety assessment strategies. The VHP is built on tools and services, including pharmacokinetic and computational models, and integrates several data sources within each case study, including data on human physiology, epidemiology, toxicokinetic and -dynamic parameters, as well as data on chemical characteristics and exposures. In addition, the VHP integrates new data generated within the project using new approach methodologies representing key events within adverse outcome pathways. Implementation of the VHP is investigated using an innovation systems approach, engaging stakeholders, and organizing training and education. Central to the VHP4Safety project is our co-creative approach, which is facilitated by biannual designathons and hackathons that foster active involvement of all project participants from over 30 partner organizations. By integrating technological innovations with transparency and stakeholder collaboration, the VHP4Safety project will help shape the transition to next generation safety assessment in which animal testing becomes redundant.
AB - The Virtual Human Platform for Safety Assessment (VHP4Safety) project aims to build a virtual human platform (VHP) to protect human health and revolutionize the safety assessment of chemicals and pharmaceuticals by transitioning from animal-based to human-based approaches. The goal of this article is to introduce the project and its interdisciplinary approach to co-creation with multiple academic, regulatory, industrial and societal partners covering the entire safety assessment knowledge chain. Three research lines drive the project: 1) building the VHP; 2) feeding the VHP with human data; and 3) implementing the VHP. The project focusses on three case studies that incorporate human-relevant scenarios not included in current animal-based safety assessment strategies. The VHP is built on tools and services, including pharmacokinetic and computational models, and integrates several data sources within each case study, including data on human physiology, epidemiology, toxicokinetic and -dynamic parameters, as well as data on chemical characteristics and exposures. In addition, the VHP integrates new data generated within the project using new approach methodologies representing key events within adverse outcome pathways. Implementation of the VHP is investigated using an innovation systems approach, engaging stakeholders, and organizing training and education. Central to the VHP4Safety project is our co-creative approach, which is facilitated by biannual designathons and hackathons that foster active involvement of all project participants from over 30 partner organizations. By integrating technological innovations with transparency and stakeholder collaboration, the VHP4Safety project will help shape the transition to next generation safety assessment in which animal testing becomes redundant.
KW - animal testing
KW - chemicals
KW - human health
KW - pharmaceuticals
KW - toxicology
U2 - 10.14573/altex.2407211
DO - 10.14573/altex.2407211
M3 - Article
SN - 1868-8551
VL - 42
SP - 111
EP - 120
JO - ALTEX
JF - ALTEX
IS - 1
ER -